People with chronic itching conditions such as eczema and psoriasis are at increased risk of stress, depression, and suicidal thoughts than those without such skin conditions.
Researchers have identified a new compound that appears to treat chronic intractable itch without the adverse side effects normally associated with medicating the condition.
Opioid receptors involved in itch relief, a new study reports.
Researchers investigated how the nervous system interacts with the immune system to cause the inflammation and itching associated with eczema. The findings could lead to new treatment options for eczema sufferers.